Chevy Chase Trust
CVS icon

Chevy Chase Trust’s CVS Health CVS Stock Holding History

Chevy Chase Trust’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$46.1M Sell
641,369
-14,577
-2% -$1.12M 0.13% 136
2025
Q4 		$52.1M Sell
655,946
-3,701
-0.6% -$292K 0.14% 130
2025
Q3 		$49.7M Sell
659,647
-22,038
-3% -$1.51M 0.14% 137
2025
Q2 		$47M Buy
681,685
+6,368
+0.9% +$418K 0.14% 142
2025
Q1 		$45.8M Sell
675,317
-78,214
-10% -$4.68M 0.15% 137
2024
Q4 		$33.8M Sell
753,531
-187,613
-20% -$10.5M 0.1% 175
2024
Q3 		$59.2M Buy
941,144
+18,734
+2% +$1.09M 0.18% 108
2024
Q2 		$54.5M Sell
922,410
-689,871
-43% -$43.2M 0.17% 114
2024
Q1 		$129M Sell
1,612,281
-12,387
-0.8% -$946K 0.42% 47
2023
Q4 		$128M Sell
1,624,668
-46,758
-3% -$3.33M 0.46% 43
2023
Q3 		$117M Buy
1,671,426
+153,620
+10% +$10.9M 0.46% 44
2023
Q2 		$105M Buy
1,517,806
+228,518
+18% +$16.3M 0.39% 57
2023
Q1 		$95.8M Sell
1,289,288
-350,888
-21% -$29.4M 0.38% 60
2022
Q4 		$153M Sell
1,640,176
-179,615
-10% -$17.3M 0.65% 33
2022
Q3 		$174M Buy
1,819,791
+469,559
+35% +$46.5M 0.74% 24
2022
Q2 		$125M Buy
1,350,232
+11,246
+0.8% +$1.1M 0.52% 37
2022
Q1 		$136M Buy
1,338,986
+28,785
+2% +$3.02M 0.47% 42
2021
Q4 		$135M Buy
1,310,201
+60,764
+5% +$5.62M 0.44% 48
2021
Q3 		$106M Sell
1,249,437
-27,805
-2% -$2.33M 0.37% 61
2021
Q2 		$107M Sell
1,277,242
-12,840
-1% -$1.05M 0.36% 60
2021
Q1 		$97.1M Sell
1,290,082
-19,665
-2% -$1.43M 0.35% 67
2020
Q4 		$89.4M Sell
1,309,747
-154,484
-11% -$10M 0.32% 74
2020
Q3 		$85.5M Sell
1,464,231
-51,868
-3% -$3.23M 0.34% 72
2020
Q2 		$98.5M Sell
1,516,099
-77,276
-5% -$4.87M 0.4% 56
2020
Q1 		$94.5M Buy
1,593,375
+97,061
+6% +$6.48M 0.44% 56
2019
Q4 		$111M Buy
1,496,314
+2,485
+0.2% +$174K 0.42% 55
2019
Q3 		$94.2M Buy
1,493,829
+113,637
+8% +$6.73M 0.39% 66
2019
Q2 		$75.2M Buy
1,380,192
+779
+0.1% +$42K 0.31% 74
2019
Q1 		$75M Sell
1,379,413
-188,340
-12% -$11.6M 0.31% 76
2018
Q4 		$103M Buy
1,567,753
+273,472
+21% +$20.4M 0.5% 44
2018
Q3 		$102M Sell
1,294,281
-19,016
-1% -$1.36M 0.42% 57
2018
Q2 		$84.5M Sell
1,313,297
-8,504
-0.6% -$560K 0.37% 66
2018
Q1 		$82.2M Sell
1,321,801
-49,142
-4% -$3.53M 0.37% 66
2017
Q4 		$99.4M Sell
1,370,943
-124,319
-8% -$9.04M 0.43% 48
2017
Q3 		$122M Sell
1,495,262
-53,195
-3% -$4.21M 0.55% 41
2017
Q2 		$125M Buy
1,548,457
+115,371
+8% +$9.11M 0.6% 35
2017
Q1 		$112M Buy
1,433,086
+13,168
+0.9% +$1.05M 0.55% 39
2016
Q4 		$112M Sell
1,419,918
-21,509
-1% -$1.74M 0.59% 36
2016
Q3 		$128M Sell
1,441,427
-15,071
-1% -$1.42M 0.7% 30
2016
Q2 		$139M Buy
1,456,498
+41,188
+3% +$4.1M 0.78% 26
2016
Q1 		$147M Buy
1,415,310
+26,048
+2% +$2.53M 0.84% 24
2015
Q4 		$136M Buy
1,389,262
+14,632
+1% +$1.43M 0.8% 28
2015
Q3 		$133M Buy
1,374,630
+45,572
+3% +$4.79M 0.83% 24
2015
Q2 		$139M Buy
1,329,058
+32,985
+3% +$3.37M 0.83% 22
2015
Q1 		$134M Buy
1,296,073
+27,906
+2% +$2.82M 0.81% 21
2014
Q4 		$122M Sell
1,268,167
-925
-0.1% -$81.5K 0.76% 26
2014
Q3 		$101M Buy
1,269,092
+98,124
+8% +$7.74M 0.65% 30
2014
Q2 		$88.3M Buy
1,170,968
+7,442
+0.6% +$562K 0.61% 36
2014
Q1 		$87.1M Buy
1,163,526
+30,349
+3% +$2.14M 0.62% 35
2013
Q4 		$81.1M Sell
1,133,177
-1,190
-0.1% -$76.5K 0.59% 37
2013
Q3 		$64.4M Buy
1,134,367
+34,966
+3% +$2.08M 0.53% 38
2013
Q2 		$62.9M Buy
+1,099,401
New +$63.7M 0.55% 35

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Chevy Chase Trust's CVS Position: Q1 2026 in Review

Chevy Chase Trust reduced its CVS Health (CVS) stake by 2.2% in Q1 2026, selling an estimated $1.12M and leaving 641,369 shares worth $46.1M. The position accounts for 0.13% of the portfolio, ranked #136.

Chevy Chase Trust first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $174M in Q3 2022. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Chevy Chase Trust held 641,369 shares of CVS Health worth $46.1M as of Q1 2026.
  • Chevy Chase Trust sold 14,577 CVS Health shares in Q1 2026, an estimated $1.12M.
  • CVS Health made up 0.13% of Chevy Chase Trust's portfolio in Q1 2026, its #136 holding.
  • Chevy Chase Trust first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Chevy Chase Trust's CVS Health position peaked at $174M in Q3 2022.
  • 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Chevy Chase Trust's 13F filing for Q1 2026, filed 15 May 2026.